Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 11.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 15.50
  • 52 Week Low: 8.20
  • Currency: UK Pounds
  • Shares Issued: 636.17m
  • Volume: 12,187
  • Market Cap: 71.57m
  • RiskGrade: 184

AGY Overview

Allergy Therapeutics is in the pharma and biotech sector and is currently trading at 11.25p per share. In the last year Allergy Therapeutics's share price has ranged from 8.20p to 15.50p and brokers are currently rating this stock as 'buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 6.0% -6.1%
ROCE 12.3%  
Latest F'cast
P/E 20.5 n/a
PEG n/a n/a
Pr/Revenue 1.0 0.9
Pr/Book 1.9  
Latest F'cast
Revenue 7.9% 8.6%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

AGY Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-15 43.00 0.65 0.02p 1,093.7 n/a -88% n/a 0.0%
30-Jun-16 48.51 (12.06) (2.29)p n/a n/a n/a n/a 0.0%
30-Jun-17 64.14 (2.48) (0.42)p n/a n/a n/a n/a 0.0%
30-Jun-18 68.35 (6.90) (1.27)p n/a n/a n/a n/a 0.0%
30-Jun-19 73.72 4.29 0.55p 25.5 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AGY Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-20 80.09 (4.86) (0.66)p n/a n/a n/a n/a 0.0%
30-Jun-21 86.32 (11.33) (1.96)p n/a n/a n/a n/a 0.0%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Latest AGY Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

AGY Market Data

Currency UK Pounds
Share Price 11.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 15.50
52 Week Low 8.20
Volume 12,187
Shares Issued 636.17m
Market Cap 71.57m
RiskGrade 184

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
31.85% below the market average31.85% below the market average31.85% below the market average31.85% below the market average31.85% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Price Trend
63.74% below the market average63.74% below the market average63.74% below the market average63.74% below the market average63.74% below the market average
29.82% below the sector average29.82% below the sector average29.82% below the sector average29.82% below the sector average29.82% below the sector average
Income Not Available
Growth
0.88% above the market average0.88% above the market average0.88% above the market average0.88% above the market average0.88% above the market average
29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AGY Dividends

No dividends found

Trades for 24-Jan-2020

Time Volume / Share Price
16:06 6,009 @ 11.23p
15:58 5,678 @ 11.23p
14:01 500 @ 11.23p

AGY Key Personnel

CEO Manuel Llobet
Finance Director Nicolas Wykeman

Top of Page